Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Puberty Blocker Petition Raises Questions About When FDA Should Weigh In On Off-Label Drug Use
Dec 12 2023
•
By
Sarah Karlin-Smith
Citizen petition wants FDA to act as umpire in political debate over off-label use of puberty blocking drugs in children. • Source: Shutterstock
More from Archive
More from Pink Sheet